Brooklyn ImmunoTherapeutics (NYSE:BTX) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Shares of Brooklyn ImmunoTherapeutics stock opened at $7.13 on Wednesday. The stock has a market cap of $419.43 million, a […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Shares of Brooklyn ImmunoTherapeutics stock opened at $7.13 on Wednesday. The stock has a market cap of $419.43 million, a […]
